{
    "organizations": [],
    "uuid": "1d8803fce82501a98c5ec91ab6c61c9d5af6f9aa",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-destiny-pharma-says-fda-accepted-i/brief-destiny-pharma-says-fda-accepted-inda-for-xf-73-idUSFWN1QG0H1",
    "ord_in_thread": 0,
    "title": "BRIEF-Destiny Pharma Says FDA Accepted INDA For Xf-73​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Destiny Pharma Plc:\n* ‍ANNOUNCES THAT US FDA ACCEPTED AN INVESTIGATIONAL NEW DRUG APPLICATION (IND) FOR COMPANY‘S LEAD CLINICAL DRUG CANDIDATE, XF-73​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-26T15:52:00.000+02:00",
    "crawled": "2018-02-27T14:53:14.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "destiny",
        "pharma",
        "plc",
        "u",
        "fda",
        "accepted",
        "investigational",
        "new",
        "drug",
        "application",
        "ind",
        "company",
        "lead",
        "clinical",
        "drug",
        "candidate",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}